NCT03595059: A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors |
|
|
| Active, not recruiting | 1 | 169 | Europe, Canada, Japan, US, RoW | ABBV-155, Paclitaxel, Docetaxel | AbbVie | Advanced Solid Tumors | 12/24 | 12/24 | | |
